Ehrlich Christopher B 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-04+119,486→ 119,486 totalExercise: $1.43Exp: 2035-03-03→ Common Stock (119,486 underlying)
Footnotes (1)
- [F1]Represents the 50% time-based portion of an award of options to purchase 238,971 shares, vesting on the nine month anniversary of the grant date, with the remaining portion subject to performance conditions.